InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 250.00
-15.50 (-5.84%)
Apr 29, 2026, 5:24 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 137.8 million as of April 29, 2026. Its market cap has decreased by -44.59% in one year.
Market Cap
137.80M
Enterprise Value
266.65M
Revenue
243.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
250.00
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 137.80M, an increase of 2,050.15%. That is a compound annual growth rate of 22.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 145.18M | -17.95% |
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 108.44B |
| Danel (Adir Yeoshua) | 2.78B |
| Amal Holdings A.D. | 2.35B |
| BrainsWay | 1.93B |
| Geffen Residence & Renewal | 347.62M |
| Epitomee Medical | 251.95M |
| Golden House | 169.13M |
| Rekah Pharmaceutical Industry | 135.04M |